795 related articles for article (PubMed ID: 14768792)
21. Mega dose methylprednisolone (MDMP) treatment.
Ozsoylu S
Turk J Pediatr; 2004; 46(3):292; author reply 293. PubMed ID: 15503490
[No Abstract] [Full Text] [Related]
22. Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases.
Baronci C; Petrone A; Miano C; Lombardi A; Caniglia M; Russo LA; Luciani M; Pinto RM; Rana I; Caruso R; De Rossi G
Ann Ist Super Sanita; 1998; 34(4):457-61. PubMed ID: 10234876
[TBL] [Abstract][Full Text] [Related]
23. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Papagianni A; Economou M; Tragiannidis A; Karatza E; Tsatra I; Gombakis N; Athanassiadou-Piperopoulou F; Athanasiou-Metaxa M
J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
[TBL] [Abstract][Full Text] [Related]
24. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
[TBL] [Abstract][Full Text] [Related]
25. The effects of megadose methylprednisolone therapy on the immune system in childhood immune thrombocytopenia.
Yetgin S; Yenicesu IC; Ersoy F
Pediatr Hematol Oncol; 2005; 22(5):401-7. PubMed ID: 16020130
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
[TBL] [Abstract][Full Text] [Related]
27. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia.
Van Riet FA; Wessels G; Hesseling PB
East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508
[TBL] [Abstract][Full Text] [Related]
28. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children.
Son DW; Jeon IS; Yang SW; Cho SH
J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936
[TBL] [Abstract][Full Text] [Related]
29. Intravenous gamma globulin for treatment of chronic idiopathic thrombocytopenic purpura in children.
Laosombat V; Wiriyasateinkul A; Wongchanchailert M
J Med Assoc Thai; 2000 Feb; 83(2):160-8. PubMed ID: 10710885
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of immune thrombocytopenic purpura in Pediatrics. Therapeutic efficacy of a regional intravenous immunoglobulin G].
Buteler C; Colombo H; Gabosi G; Manfredi MJ; Montero S; Pasquali MA; Rougier C; Sisti AM
Medicina (B Aires); 2001; 61(5 Pt 1):522-8. PubMed ID: 11721317
[TBL] [Abstract][Full Text] [Related]
31. Idiopathic thrombocytopenic purpura (ITP) in children.
Baronci C; Pansini V; Funaro D; Coletti V; Caruso R; De Rossi G
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):665-7. PubMed ID: 16933259
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
[TBL] [Abstract][Full Text] [Related]
33. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey.
Marks MK; Vadamalayan B; Ekert H; South MJ
J Paediatr Child Health; 2005; 41(1-2):52-5. PubMed ID: 15670225
[TBL] [Abstract][Full Text] [Related]
34. [Intravenous high-dose methylprednisolone efficacy for treatment of idiopathic thrombocytopenic purpura in adults].
Visser R; Zweegman S; Ossenkoppele GJ; Huijgens PC
Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2053-7. PubMed ID: 10560547
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
Freiberg A; Mauger D
Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
[TBL] [Abstract][Full Text] [Related]
36. Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
Blackhouse G; Xie F; Levine MA; Campbell K; Assasi N; Gaebel K; O'Reilly D; Tarride J; Goeree R
J Popul Ther Clin Pharmacol; 2012; 19(2):e166-78. PubMed ID: 22580389
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
Simpson KN; Coughlin CM; Eron J; Bussel JB
Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
[TBL] [Abstract][Full Text] [Related]
38. Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.
Celik M; Bulbul A; Aydogan G; Tugcu D; Can E; Uslu S; Dursun M
J Thromb Thrombolysis; 2013 Feb; 35(2):228-33. PubMed ID: 22956408
[TBL] [Abstract][Full Text] [Related]
39. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?].
Masłowska E; Wysocki M; Michalak-Nowaczyk A
Pediatr Pol; 1996 Jan; 71(1):25-9. PubMed ID: 8966063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
